ZIMVV ZIMVIE INC

ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference

ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference

PALM BEACH GARDENS, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming Stifel 2025 Jaws & Paws Conference. Management will be presenting on Wednesday, May 28, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time.

A live webcast of the event, as well as an archived recording will be available on ZimVie’s investor website at .

About ZimVie

ZimVie is a global life sciences leader in the dental market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at . Follow @ZimVie on , , , or .

Media Contact Information:

ZimVie

Grace Flowers •

(561) 319-6130

Investor Contact Information:

Gilmartin Group LLC

Webb Campbell •



EN
14/05/2025

Underlying

ZIMVVZIMVIE INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZIMVIE INC

 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $...

ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash Transaction expected to close by year-end 2025 PALM BEACH GARDENS, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”), an investment firm focused exclusively on healthcare industries. Under the terms of the merger agreement, ZimVie stockholders will receive $19.00 in...

17h / 47m 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite an...

ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in Japan Innovative digital dentistry experience empowers greater efficiency, accuracy, and esthetic outcomes in dental care PALM BEACH GARDENS, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its RealGUIDE® Software Suite and Implant Concierge® service in Japan. The launch of RealGUIDE and Implant Concierge in Japan expands dentists’ access to a unique digital dental implant ecosy...

June 5, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference

ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference PALM BEACH GARDENS, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming Stifel 2025 Jaws & Paws Conference. Management will be presenting on Wednesday, May 28, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the event, as well as an archived recording will be available on ZimVie’s investor website at . About ZimVieZimVie is a global life sciences leader in the dental mark...

May 14, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Reports First Quarter 2025 Financial Results

ZimVie Reports First Quarter 2025 Financial Results Net Sales from Continuing Operations of $112.0 millionNet Loss from Continuing Operations of $(2.6) million; Net Loss margin of (2.3)% Adjusted EBITDA[1] from Continuing Operations of $17.6 million; Adjusted EBITDA[1] margin of 15.7%GAAP diluted EPS from Continuing Operations of $(0.09) and adjusted diluted EPS[1] from Continuing Operations of $0.27 PALM BEACH GARDENS, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter en...

May 8, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025

ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025 PALM BEACH GARDENS, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should . Participants are encouraged to register more than 15 minutes before the start of the call. A replay of ...

April 24, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch